The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corline Biomedical AB
STO:CLBIO
|
SE |
|
Compagnie Generale des Etablissements Michelin SCA
OTC:MGDDF
|
FR |
|
T Rowe Price Group Inc
NASDAQ:TROW
|
US |
|
International Consolidated Airlines Group SA
LSE:IAG
|
UK |
|
Samsung C&T Corp
KRX:028260
|
KR |
|
N
|
NSL Foods PCL
SET:NSL
|
TH |
|
W
|
Wise iTech Co Ltd
KOSDAQ:065370
|
KR |
|
Trutankless Inc
OTC:TKLS
|
US |
|
A
|
Avista Corp
F:AV6
|
US |
|
D
|
Duksan Techopia Co Ltd
KOSDAQ:317330
|
KR |
|
B
|
BGFEcomaterials Co Ltd
KOSDAQ:126600
|
KR |
|
F
|
Fresenius SE & Co KGaA
XHAM:FRE
|
DE |
|
T
|
Tractor Supply Co
F:TR4
|
US |
|
Polaris Media ASA
OSE:POL
|
NO |
|
S
|
SCC Holdings Bhd
KLSE:SCC
|
MY |
|
C
|
Cube Entertainment Inc
KOSDAQ:182360
|
KR |
|
K
|
KLA Corp
XMUN:KLA
|
US |
|
Dropbox Inc
NASDAQ:DBX
|
US |
|
S
|
Sirius XM Holdings Inc
F:3HY
|
US |
|
A
|
Algoma Steel Group Inc
TSX:ASTL
|
CA |
|
S
|
Sunstone Hotel Investors Inc
F:UF2
|
US |
|
Omni Health Inc
OTC:OMHE
|
US |
|
F
|
Fideicomiso Irrevocable No 188156
BMV:FCFE18
|
MX |
|
Q
|
Quest Diagnostics Inc
XMUN:QDI
|
US |
Corline Biomedical AB (CLBIO)’s 12-month stock price forecast through October 2027 has a consensus target of kr29.58, implying 95% upside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
CLBIO is 29.58 SEK with a low forecast of 29.29 SEK and a high forecast of 30.45 SEK.
Over the last 11 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 136%.
Over the last 11 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next -1 years is -68%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more